Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photothermally activated versus non-activated platelet-rich plasma for androgenetic alopecia
TCTR20260701009Phase 2Active, not recruiting
- Sponsor
- Thammasat University
- Start
- Jul 2025
- Countries
- 1
01
Overview
A Phase 2 trial of platelet-rich plasma in androgenetic alopecia (AGA), sponsored by Thammasat University. Started Jul 2025; status: active, not recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on TCTR20260701009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260701009.